Literature DB >> 2792381

Molecular cloning and predicted full-length amino acid sequence of the type I beta isozyme of cGMP-dependent protein kinase from human placenta. Tissue distribution and developmental changes in rat.

M Sandberg1, V Natarajan, I Ronander, D Kalderon, U Walter, S M Lohmann, T Jahnsen.   

Abstract

In this study we report the isolation and characterization of three overlapping cDNA clones for the type I beta isozyme of cGMP-dependent protein kinase (cGK) from human placenta libraries. The composite sequence was 3740 nucleotides long and contained 58 nucleotides from the 5'-noncoding region, an open reading frame of 2061 bases including the stop codon, and a 3'-noncoding region of 1621 nucleotides. The predicted full-length human type I beta cGK protein contained 686 amino acids including the initiator methionine, and had an estimated molecular mass of 77,803 Da. On comparison to the published amino acid sequence of bovine lung I alpha, human placenta I beta cGK differed by only two amino acids in the carboxyl-terminal region (amino acids 105-686). In contrast, the amino-terminal region of the two proteins was markedly different (only 36% similarity), and human I beta cGK was 16 amino acids longer. In a specific region in the amino-terminus (amino acids 63-75), 12 out of 13 amino acids of the human I beta cGK were identical to the partial amino acid sequence recently published for a new I beta isoform of cGK from bovine aorta. Northern blot analysis demonstrated a human I beta cGK mRNA, 7 kb in size, in human uterus and weakly in placenta. An mRNA of 7 kb was also observed in rat cerebellum, cerebrum, lung, kidney, and adrenal, whereas an mRNA doublet of 7.5 and 6.5 kb were observed in rat heart. Comparison of Northern and Western blot analyses demonstrated that the mRNA and protein for cerebellar cGK increased during the development of rats from 5 to 30 days old, whereas the 6.5 kb mRNA in rat heart declined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792381     DOI: 10.1016/0014-5793(89)81114-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.

Authors:  Jun Kotera; Kennard A Grimes; Jackie D Corbin; Sharron H Francis
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

2.  Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase.

Authors:  Michael E Wall; Sharron H Francis; Jackie D Corbin; Kennard Grimes; Robyn Richie-Jannetta; Jun Kotera; Brian A Macdonald; Rowena R Gibson; Jill Trewhella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

3.  Regulation of gene expression by cyclic GMP-dependent protein kinase requires nuclear translocation of the kinase: identification of a nuclear localization signal.

Authors:  T Gudi; S M Lohmann; R B Pilz
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Authors:  Thomas M Moon; Nathan R Tykocki; Jessica L Sheehe; Brent W Osborne; Werner Tegge; Joseph E Brayden; Wolfgang R Dostmann
Journal:  Chem Biol       Date:  2015-12-17

5.  Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes.

Authors:  P F Méry; S M Lohmann; U Walter; R Fischmeister
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

6.  Differential VASP phosphorylation controls remodeling of the actin cytoskeleton.

Authors:  Peter M Benz; Constanze Blume; Stefanie Seifert; Sabine Wilhelm; Jens Waschke; Kai Schuh; Frank Gertler; Thomas Münzel; Thomas Renné
Journal:  J Cell Sci       Date:  2009-10-13       Impact factor: 5.285

7.  A gene encoding a protein related to eukaryotic protein kinases from the filamentous heterocystous cyanobacterium Anabaena PCC 7120.

Authors:  C C Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.

Authors:  E Butt; D Pöhler; H G Genieser; J P Huggins; B Bucher
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

9.  Membrane targeting of cGMP-dependent protein kinase is required for cystic fibrosis transmembrane conductance regulator Cl- channel activation.

Authors:  A B Vaandrager; A Smolenski; B C Tilly; A B Houtsmuller; E M Ehlert; A G Bot; M Edixhoven; W E Boomaars; S M Lohmann; H R de Jonge
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

10.  Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator.

Authors:  T Markert; A B Vaandrager; S Gambaryan; D Pöhler; C Häusler; U Walter; H R De Jonge; T Jarchau; S M Lohmann
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.